Tissue plasminogen activator infusion as
โ
Aekarach Ariyachaipanich; Olatokunbo Oyejola; Arafat Melhem; Vinaya Soundararaja
๐
Article
๐
2010
๐
Wiley (John Wiley & Sons)
๐
English
โ 105 KB
## Abstract ## BACKGROUND The formation of a fibrin sheath thrombus is the most common cause of hemodialysis catheter dysfunction (HCD). The infusion of a lowโdose recombinant tissue plasminogen activator (rtPA) has been shown to be safe and effective. However, there is no consensus as to the opti